Effects of genetic variation in the aldosterone synthase (CYP11B2) gene on enzyme function

Clinical Endocrinology

Volumn 70, Issue 3, 2009, Pages 363-371

  Holloway, C D ^a   MacKenzie, S M ^a   Fraser, R ^a   Miller, S ^a   Barr, M ^a   Wilkinson, D ^a   Forbes, G H ^a   Friel, E ^a   Connell, J M C ^a   Davies, E ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ALDOSTERONE; ALDOSTERONE SYNTHASE; ARGININE; ASPARAGINE; ASPARTIC ACID; CORTICOSTERONE; DEOXYCORTICOSTERONE; GLYCINE; HISTONE; LYSINE; TYROSINE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; FEMALE; GENE SEQUENCE; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MALE; NORMAL HUMAN; PLASMID; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SYNTHESIS; WILD TYPE;

ADULT; AGED; ALDOSTERONE; ALDOSTERONE SYNTHASE; CORTICOSTERONE; FEMALE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE ANALYSIS, DNA;

EID: 60349127030     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03383.x     Document Type: Article

References (42)

1. Kearney, P., Whelton, M., Reynolds, K. et al. (2005) Global burden of hypertension: analysis of worldwide data. Lancet, 365, 217 223.
2. Lifton, R.P. (1996) Molecular genetics of human blood pressure variation. Science, 272, 676 680.
3. Gordon, R.D., Stowasser, M., Tunny, T.J. et al. (1994) High incidence of primary aldosteronism in 199 patients referred with hypertension. Clinical and Experimental Pharmacology and Physiology, 21, 315 318.
4. Lim, P.O., MacDonald, T.M., Holloway, C.D. et al. (2002) Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone to renin ratio. Journal of Clinical Endocrinology and Metabolism, 87, 4398 4402.
5. Rayner, B.L., Opie, L.H. Davidson, J.S. (2000) The aldosterone/renin ratio as a screening test for primary aldosteronism. South African Medical Journal, 90, 394 400.
6. Pitt, B., Zannad, F., Remme, W.J. et al. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. New England Journal of Medicine, 341, 709 716.
7. Pitt, B., Remme, W., Zannad, F. et al. (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. New England Journal of Medicine, 348, 1309 1321.
8. Fraser, R. Lantos, C.P. (1978) 18-Hydroxycorticosterone: a review. Journal of Steroid Biochemistry, 9, 273 286.
9. Ulick, S. Chu, M. (1982) Hypersecretion of a new corticosteroid, 18-hydroxycortisol in two types of adrenocortical hypertension. Clinical and Experimental Hypertension, A4, 1771 1777.
10. Lieberman, S., Ma, S. He, Y. (2005) New assumptions about oxidative processes involved in steroid hormone biosynthesis: is the role of cytochrome P-450-activated dioxygen limited to hydroxylation reactions or are dioxygen insertion reactions also possible? Journal of Steroid Biochemistry, 94, 405 420.
11. Brownie, A.C., Alfano, J. Gallant, S. (1990) Rat models of experimental hypertension. In : E.G. Biglieri, J.C. Melby eds. Endocrine Hypertension. Raven Press, New York, 29 69.
12. White, P.C. Slutsker, L. (1995) Haplotype analysis of CYP11B2. Endocrine Research, 21, 437 442.
13. Bassett, M.H., White, P.C. Rainey, W.E. (2004) The regulation of aldosterone synthase expression. Molecular and Cellular Endocrinology, 217, 67 74.
14. Paillard, F., Chansel, D., Brand, E. et al. (1999) Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension, 34, 423 429.
15. Davies, E., Holloway, C.D., Ingram, M.C. et al. (1999) Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene Cyp11B2. Hypertension, 33, 703 707.
16. Kumar, N.N., Benjafield, A.V., Lin, R.C.Y. et al. (2003) Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows association with essential hypertension. Journal of Hypertension, 21, 1331 1337.
17. Sookoian, S., Gianotti, T.F., Gonzalez, C.D. et al. (2007) Association of the C-344T aldosterone synthase gene variant with essential hypertension: a meta-analysis. Journal of Hypertension, 25, 5 13.
18. Kupari, M., Hautanen, A., Lankinen, L. et al. (1998) Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation, 97, 569 575.
19. Fardella, C.E., Rodriguez, H., Montero, J. et al. (1996) Genetic variation in P450c11AS in Chilean patients with low renin hypertension. Journal of Clinical Endocrinology and Metabolism, 81, 4347 4351.
20. Komiya, I., Yamada, T., Takara, M. et al. (2000) Lys173Arg and -344T/C variants of CYP11B2 in Japanese patients with low-renin hypertension. Hypertension, 35, 699 703.
21. Barr, M., MacKenzie, S.M., Wilkinson, D.M. et al. (2006) Functional effects of genetic variants in the 11B-hydroxylase (CYP11B1) gene. Clinical Endocrinology, 65, 816 825.
22. Inglis, G.C., Plouin, P.F., Friel, E.C. et al. (2001) Polymorphic differences from normal in the aldosterone synthase gene (CYP11B2) in patients with primary hyperaldosteronism and adrenal tumour (Conn's syndrome). Clinical Endocrinology, 54, 725 730.
23. Fisher, A., Fraser, R., Connell, J.M.C. et al. (2000) Amino acid 147 of human aldosterone synthase and 11β-hydroxylase plays a key role in 11β-hydroxylation. Journal of Clinical Endocrinology and Metabolism, 85, 1261 1266.
24. Ye, P., Kenyon, C.J., MacKenzie, S.M. et al. (2003) Regulation of aldosterone synthase gene expression in the rat adrenal gland and central nervous system by sodium and angiotensin II. Endocrinology, 144, 3321 3328.
25. Cargill, M., Altshuler, D., Ireland, J. et al. (1999) Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nature Genetics, 22, 231 238.
26. Sheffield Val, C., Beck John, S., Sandstrom Dirk, W. et al. (1993) The sensitivity of single-strand polymorphism analysis for the detection of single base substitutions. Genomics, 16, 325 332.
27. Portrat-Doyen, S., Tourniaire, J., Richard, O. et al. (1998) Isolated aldosterone synthase deficiency caused by simultaneous E198D and V386A mutations in the CYP11B2 gene. Journal of Clinical Endocrinology and Metabolism, 83, 4156 4161.
28. Belkina, N.V., Lisurek, M., Ivanov, A.S. et al. (2001) Modelling of three-dimensional structures of cytochromes P450 11B1 and 11B2. Journal of Inorganic Biochemistry, 87, 197 207.
29. Ravichandran, K., Boddupalli, S., Hasemann, C. et al. (1993) Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450s. Science, 261, 731 736.
30. Roumen, L., Sanders, M.P.A., Pieterse, K. et al. (2007) Construction of 3D models of the CYP11B family as a tool to predict ligand binding characteristics. Journal of Computer-Aided Molecular Design Incorporating Perspectives in Drug Discovery and Design, 21, 455 471.
31. Lisurek, M. Bernhardt, R. (2004) Modulation of aldosterone and cortisol synthesis on the molecular level. Molecular and Cellular Endocrinology, 215, 149 159.
32. Gotoh, O. (1992) Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analysis of amino acid and coding nucleotide sequences. The Journal of Biological Chemistry, 267, 83 90.
33. Mulatero, P., Glorisio, N., Fallo, F. et al. (2001) Absence of D147E mutation of CYP11B2 gene in patients with increased corticosterone and aldosterone production. European Journal of Endocrinology, 144, 397 400.
34. Fardella, C.E., Rodriguez, H., Hum, D.W. et al. (1995) Artificial mutations in P450c11AS (aldosterone synthase) can increase enzymatic activity: a model for low-renin hypertension? Journal of Clinical Endocrinology and Metabolism, 80, 1040 1043.
35. Betchel, S., Belkina, N. Bernhardt, R. (2002) The effect of amino-acid substitutions I112P, D147E and K152N in CYP11B2 on the catalytic activities of the enzyme. European Journal of Biochemistry, 269, 1118 1127.
36. Bottner, B. Bernhardt, R. (1996) Changed ratios of glucocorticoids/ mineralocorticoids caused by point mutations in the putative i-helix regions of CYP11B1 and CYP11B2. Endocrine Research, 22, 455 461.
37. Peterson, J.A. Graham, S.E. (1998) A close family resemblance: the importance of structure in understanding cytochromes P450. Structure, 6, 1079 1085.
38. Curnow, K.M., Mulatero, P., Emeric-Blanchouin, N. et al. (1997) The amino acid substitutions ser288gly and val320ala convert the cortisol producing enzyme, CYP11B1, into an aldosterone producing enzyme. Nature Structural and Molecular Biology, 4, 32 35.
39. Geley, S., Johrer, K., Peter, M. et al. (1995) Amino acid substitution R384P in aldosterone synthase causes corticosterone methyloxidase type I deficiency. Journal of Clinical Endocrinology and Metabolism, 80, 424 429.
40. Nomoto, S., Massa, G., Mitani, F. et al. (1997) CMO I deficiency caused by a point mutation in exon 8 of the human CYP11B2 gene encoding steroid 18-hydroxylase P450 (C18). Biochemical and Biophysical Research Communications, 234, 382 385.
41. Nguyen, H.H., Hannemann, F., Hartmann, M.F. et al. (2008) Aldosterone synthase deficiency caused by a homozygous L451F mutation in the CYP11B2 gene. Molecular Genetics and Metabolism, 93, 458 467.
42. White, P.C. (2004) Aldosterone synthase deficiency and related disorders. Molecular and Cellular Endocrinology, 217, 81 87.